Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Bevacizumab in Elderly mCRC
NCT00107315Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jul 2004
- Primary completion
- Jun 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roswell Park Comprehensive Cancer Center. Started Jul 2004; status: terminated.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00107315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107315.